Alison Yung

The SPEAK study rationale and design: A linguistic corpus-based approach to understanding thought disorder.

JMM Bayer, J Spark, M Krcmar, M Formica, K Gwyther, A Srivastava, A Selloni, M Cotter, J Hartmann, A Polari, ZR Bilgrami, C Sarac, A Lu, Alison R Yung, A McGowan, P McGorry, JL Shah, GA Cecchi, R Mizrahi, B Nelson, et al.

Journal article  |  2023  |  Schizophr Res

AIM: Psychotic symptoms are typically measured using clinical ratings, but more objective and sensitive metrics are needed. Hence,..

Harmonizing the structured interview for psychosis-risk syndromes (SIPS) and the comprehensive assessment of at-risk mental states (CAARMS): An initial approach.

Jean Addington, Scott W Woods, Alison R Yung, Monica E Calkins, Paolo Fusar-Poli

Journal article  |  2023  |  Early Interv Psychiatry

The two most used semi-structured psychometric instruments that define criteria for being at clinical high risk (CHR) for psychosi..

Limitations and Value of Animal Models of Relevance to the Schizophrenia Prodrome.

Alison R Yung

Journal article  |  2023  |  Biol Psychiatry Glob Open Sci

A systematic review and meta-analysis of delayed help-seeking, delayed diagnosis and duration of untreated illness in bipolar disorders.

Jan Scott, Anna Graham, Alison Yung, Catherine Morgan, Frank Bellivier, Bruno Etain

Journal article  |  2022  |  Acta Psychiatr Scand

OBJECTIVES: To examine the time delay between the age at onset of symptoms or episodes of bipolar disorders (BD) and the age at di..

The role of metformin as a treatment for neuropsychiatric illness

Seetal Dodd, Luba Sominsky, Dan Siskind, Chiara C Bortolasci, Andre F Carvalho, Michael Maes, Adam J Walker, Ken Walder, Alison R Yung, Lana J Williams, Hannah Myles, Tayler Watson, Michael Berk

Journal article  |  2022  |  EUROPEAN NEUROPSYCHOPHARMACOLOGY

Advances in psychopharmacology have been significantly slower to evolve than in other disciplines of medicine and therefore invest..

Evidence that complement and coagulation proteins are mediating the clinical response to omega-3 fatty acids: A mass spectrometry-based investigation in subjects at clinical high-risk for psychosis

Subash Raj Susai, Colm Healy, David Mongan, Meike Heurich, Jonah F Byrne, Mary Cannon, Gerard Cagney, Kieran Wynne, Connie Markulev, Miriam R Schafer, Maximus Berger, Nilufar Mossaheb, Monika Schlogelhofer, Stefan Smesny, Ian B Hickie, Gregor E Berger, Eric YH Chen, Lieuwe de Haan, Dorien H Nieman, Merete Nordentoft, et al.

Journal article  |  2022  |  TRANSLATIONAL PSYCHIATRY

Preliminary evidence indicates beneficial effects of omega-3 polyunsaturated fatty acids (PUFAs) in early psychosis. The present s..

Effects of omega-3 polyunsaturated fatty acid supplementation on cognitive functioning in youth at ultra-high risk for psychosis: secondary analysis of the NEURAPRO randomised controlled trial

Nicholas Cheng, Alison McLaverty, Barnaby Nelson, Connie Markulev, Miriam R Schafer, Maximus Berger, Nilufar Mossaheb, Monika Schlogelhofer, Stefan Smesny, Ian B Hicikie, Gregor E Berger, Eric YH Chen, Lieuwe de Haan, Dorien H Nieman, Merete Nordentoft, Anita Riecher-Rossler, Swapna Verma, Rebekah Street, Andrew Thompson, Hok Pan Yuen, et al.

Journal article  |  2022  |  BJPSYCH OPEN

BACKGROUND: Cognitive impairments are well-established features of psychotic disorders and are present when individuals are at ult..

Intelligence trajectories in individuals at ultra-high risk for psychosis: An 8-year longitudinal analysis

Nicholas Cheng, Ashleigh Lin, Stephen Bowden, Caroline Gao, Alison R Yung, Barnaby Nelson, Andrew Thompson, Hok Pan Yuen, Warrick J Brewer, Daniela Cagliarini, Annie Bruxner, Magenta Simmons, Christina Broussard, Christos Pantelis, Patrick D McGorry, Kelly Allott, Stephen J Wood

Journal article  |  2022  |  SCHIZOPHRENIA RESEARCH

Cognitive impairment is a well-documented predictor of transition to a full-threshold psychotic disorder amongst individuals at ul..

After the acute crisis - engaging people with psychosis in rehabilitation-oriented care.

Dan Siskind, Alison Yung

Journal article  |  2022  |  World Psychiatry

The EMPOWER blended digital intervention for relapse prevention in schizophrenia: a feasibility cluster randomised controlled trial in Scotland and Australia

Andrew Gumley, Simon Bradstreet, John Ainsworth, Stephanie Allan, Mario Alvarez-Jimenez, Lorna Aucott, Maximillian Birchwood, Andrew Briggs, Sandra Bucci, Sue M Cotton, Lidia Engel, Paul French, Reeva Lederman, Shon Lewis, Matthew Machin, Graeme MacLennan, Hamish McLeod, Nicola McMeekin, Cathy Mihalopoulos, Emma Morton, et al.

Journal article  |  2022  |  LANCET PSYCHIATRY

BACKGROUND: Early warning signs monitoring by service users with schizophrenia has shown promise in preventing relapse but the qua..